Related Experiment Video
Updated: Mar 30, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Oral insulin delivery systems using chitosan-based formulation: a review.
Khalid Al Rubeaan1, Mohamed Rafiullah1, Sanjay Jayavanth1
1a Strategic Center for Diabetes Research, University Diabetes Center, College of Medicine , King Saud University , Riyadh , Saudi Arabia.
Developing oral insulin delivery (OID) faces challenges like enzymatic degradation and poor absorption. Chitosan-based formulations show promise, but improving in-vivo absorption is key for successful OID.
Area of Science:
- Biomaterials Science
- Pharmaceutical Sciences
- Drug Delivery Systems
Background:
- Oral insulin delivery (OID) faces significant hurdles including enzymatic proteolysis, gastric degradation, and poor absorption.
- Chitosan-based insulin formulations are being explored to overcome these natural barriers.
Purpose of the Study:
- To review and evaluate techniques for oral insulin formulations.
- To assess the performance of existing OID formulations.
- To identify future directions for OID research.
Main Methods:
- Systematic review of 86 articles on oral insulin delivery.
- Analysis of formulation techniques, primarily poly-electrolytic complexation and chemical modification.
- Evaluation of in-vitro performance using a '30x70 performance window'.
Main Results:
- Most reviewed oral insulin formulations effectively addressed gastric and enzymatic barriers.
- Formulations showed limitations in overcoming the absorption barrier of the gastrointestinal tract.
- In-vitro results indicate effectiveness, but in-vivo performance requires improvement.
Conclusions:
- Significant research efforts are focused on overcoming gastrointestinal barriers for OID.
- Current OID formulations demonstrate better performance in experimental settings than in in-vivo studies.
- Enhancing in-vivo insulin absorption through the gut is crucial for realizing practical oral insulin delivery.
More Related Videos
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
05:26Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Glinides
Oral Drug Delivery Systems: Continuous-Release Systems